Compound Detail
CHEMBL2387080
TASELISIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Cc1nc(-c2cn3c(n2)-c2ccc(-c4cnn(C(C)(C)C(N)=O)c4)cc2OCC3)n(C(C)C)n1
Basic Information
| ChEMBL ID | CHEMBL2387080 |
| Name | TASELISIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | BEUQXVWXFDOSAQ-UHFFFAOYSA-N |
11
Targets
38
Activities
3
Assay Types
13
PK Parameters
20
Publications
3
Known Names
6
Indications
1
Mechanisms
Molecular Properties
460.5
MW (Da)
3.17
ALogP
9
HBA
1
HBD
118.7
PSA (Ų)
0.49
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| PI3-kinase class I inhibitor | INHIBITOR | PI3-kinase class I | ✓ | ✓ |
Indications
Breast Neoplasms Carcinoma, Squamous Cell Multiple Myeloma Lung Neoplasms Lymphoma, Non-Hodgkin Triple Negative Breast Neoplasms
Activity Summary
Ki 23 meas. best 10.1
IC50 11 meas. best 8.4
EC50 4 meas. best 8.0
Target Activity Profile
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 178689.52 | ng.hr.mL-1 | Mus musculus |
| AUC | 178689.52 | ng.hr.mL-1 | Mus musculus |
| CL | 11.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 5.2 | mL.min-1.kg-1 | Mus musculus |
| CL | 3.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.8 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 25.0 | mL.min-1.kg-1 | Mus musculus |
| CL | 2.7 | mL.min-1.kg-1 | Mus musculus |
| CL | 41.1 | mL.min-1.kg-1 | Mus musculus |
| CL | 3.0 | mL.min-1.kg-1 | Mus musculus |
| F | 100.0 | % | Mus musculus |
| F | 99.0 | % | Rattus norvegicus |
| F | 100.0 | % | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | U2OS | 262 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 262 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 260 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| 26741947 | 10.1021/acs.jmedchem.5b01483 | Mus musculus | 7 |
| 23662903 | 10.1021/jm4003632 | Mus musculus | 7 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| 23662903 | 10.1021/jm4003632 | NON-PROTEIN TARGET | 6 |
| 23662903 | 10.1021/jm4003632 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 26741947 | 10.1021/acs.jmedchem.5b01483 | NON-PROTEIN TARGET | 4 |
| 36455032 | 10.1021/acs.jmedchem.2c01422 | Unchecked | 3 |
| 23662903 | 10.1021/jm4003632 | Hepatocyte | 3 |
| 23662903 | 10.1021/jm4003632 | Unchecked | 3 |
| 26741947 | 10.1021/acs.jmedchem.5b01483 | Unchecked | 3 |
| 23662903 | 10.1021/jm4003632 | Plasma | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 23662903 | 10.1021/jm4003632 | Rattus norvegicus | 2 |
| 23662903 | 10.1021/jm4003632 | Phosphatidylinositol 3-kinase catalytic subunit type 3 | 2 |
Data from ChEMBL 36 via Core Engine